The “Torlak” Institute is working on improving production in line with modern standards, enabling the production of BCG immune preparations alongside the standard BCG vaccine. Claims that the department for BCG vaccine production has been disbanded are not true; a reorganization of the facility is planned. The Institute emphasizes that efforts are being made to improve processes and to continue operations according to the most modern standards. The continuity of immunization is not at risk, and the availability of the BCG vaccine is not in question.
The institute is improving vaccine production standards.
